[1] |
郑荣寿,陈茹,韩冰峰,等. 2022年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志,2024,46(3):221-231.
|
[2] |
Bray F,Ferlay J,Soerjomataram I,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2018,68(6):394-424.
|
[3] |
中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗指南(2024年版)[J]. 中华外科杂志,2024,62(6):477-503.
|
[4] |
Matsas S,Aguiar PN Jr,Del Giglio A. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as biomarkers to prognosticate survival in advanced gastric cancer patients in the era of immunotherapy: a systematic review and meta-analysis[J]. J Gastrointest Oncol,2024,15(1):33-51.
|
[5] |
Muangto T,Maireang K,Poomtavorn Y,et al. Study on preoperative neutrophil/lymphocyte (NLR) and platelet/lymphocyte ratio (PLR) as a predictive factor in endometrial cancer[J]. Asian Pac J Cancer Prev,2022,23(10):3317-3322.
|
[6] |
Cao W,Yu H,Zhu S,et al. Clinical significance of preoperative neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in the prognosis of resected early-stage patients with non-small cell lung cancer: a meta-analysis[J]. Cancer Med,2023,12(6):7065-7076.
|
[7] |
Wang L,Li X,Liu M,et al. Association between monocyte-tolymphocyte ratio and prostate cancer in the U.S. population: a population-based study[J]. Front Cell Dev Biol,2024,12:1372731.
|
[8] |
Zhang H,Li Y,Liu G,et al. Expression analysis of lymphocyte subsets and lymphocyte-to-monocyte ratio: reveling immunosuppression and chronic inflammation in breast cancer[J]. J Cancer Res Clin Oncol,2024,150(1):28.
|
[9] |
Lemoine M,Shimakawa Y,Nayagam S,et al. The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa[J]. Gut,2016,65(8):1369-1376.
|
[10] |
Park YE,Kim BK,Park JY,et al. Gamma-glutamyl transpeptidase-toplatelet ratio is an independent predictor of hepatitis B virus-related liver cancer[J]. J Gastroenterol Hepatol,2017,32(6):1221-1229.
|
[11] |
王金涛,韩博强,安东均,等. 术前血清γ-谷氨酰转肽酶与血小板比值预测乙型肝炎病毒相关性肝细胞癌患者预后的预测模型构建[J]. 中国普外基础与临床杂志,2023,30(4):450-455.
|
[12] |
Dai T,Deng M,Ye L,et al. Prognostic value of combined preoperative gamma-glutamyl transpeptidase to platelet ratio and fibrinogen in patients with HBV-related hepatocellular carcinoma after hepatectomy[J]. Am J Transl Res,2020,12(6):2984-2997.
|
[13] |
Ke MY,Zhang M,Su Q,et al. Gamma-glutamyl transpeptidase to platelet ratio predicts short-term outcomes in hepatocellular carcinoma patients undergoing minor liver resection[J]. J Surg Res,2018,231:403-410.
|
[14] |
中华医学会肝病学分会,中华医学会感染病学分会. 慢性乙型肝炎防治指南(2022年版)[J]. 中华肝脏病杂志,2022,30(12):1309-1331.
|
[15] |
中华人民共和国国家卫生健康委员会医政司. 原发性肝癌诊疗指南(2024年版)[J/OL]. 中华肝脏外科手术学电子杂志,2024,13(4):407-449.
|
[16] |
Kramvis A,Chang KM,Dandri M,et al. A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook[J].Nat Rev Gastroenterol Hepatol,2022,19(11):727-745.
|
[17] |
Li S,Lu Z,Wu S,et al. The dynamic role of platelets in cancer progression and their therapeutic implications[J]. Nat Rev Cancer,2024,24(1):72-87.
|
[18] |
刘双池,庞青,谈燚. 血小板在肝细胞癌发生和转移中的研究进展[J/OL]. 中华普通外科学文献(电子版),2021,15(1):66-69.
|
[19] |
Tesfamariam B. Involvement of platelets in tumor cell metastasis[J].Pharmacol Ther,2016,157:112-119.
|
[20] |
Lavergne M,Janus-Bell E,Schaff M,et al. Platelet integrins in tumor metastasis: do they represent a therapeutic target?[J]. Cancers,2017,9(10):133.
|
[21] |
Li DZ,Guo J,Song QK,et al. Prognostic prediction of the plateletto-lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis[J]. Transl Cancer Res,2022,11(11):4037-4050.
|
[22] |
Wang D,Bai N,Hu X,et al. Preoperative inflammatory markers of NLR and PLR as indicators of poor prognosis in resectable HCC[J].PeerJ,2019,7:e7132.
|
[23] |
Hofbauer SL,Stangl KI,de Martino M,et al. Pretherapeutic gammaglutamyltransferase is an independent prognostic factor for patients with renal cell carcinoma[J]. Br J Cancer,2014,111(8):1526-1531.
|
[24] |
Wen YF,Yang XZ,Zeng LS,et al. Prognostic impact of pretherapeutic gamma-glutamyltransferase on patients with nasopharyngeal carcinoma[J]. PLoS One,2017,12(2):e0172345.
|
[25] |
Yang F,Zhang S,Yang H,et al. Prognostic significance of gammaglutamyltransferase in patients with resectable esophageal squamous cell carcinoma[J]. Dis Esophagus,2015,28(5):496-504.
|
[26] |
Luo D,Li H,Hu J,et al. Development and validation of nomograms based on gamma-glutamyl transpeptidase to platelet ratio for hepatocellular carcinoma patients reveal novel prognostic value and the ratio is negatively correlated with P38MAPK expression[J]. Front Oncol,2020,10:548744.
|
[27] |
黄琴,彭晓明,梅丽萍,等. PIVKA-Ⅱ、GGT、GPR、GLR、PLR对乙型肝炎相关性原发性肝癌的诊断价值研究[J]. 中西医结合肝病杂志,2024,34(4):327-330.
|